WO2013166169A1 - Apparatus and methods for microbiological analysis - Google Patents
Apparatus and methods for microbiological analysis Download PDFInfo
- Publication number
- WO2013166169A1 WO2013166169A1 PCT/US2013/039094 US2013039094W WO2013166169A1 WO 2013166169 A1 WO2013166169 A1 WO 2013166169A1 US 2013039094 W US2013039094 W US 2013039094W WO 2013166169 A1 WO2013166169 A1 WO 2013166169A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- proteins
- sample
- mass
- microbes
- soluble
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 147
- 238000012543 microbiological analysis Methods 0.000 title description 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 224
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 223
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 52
- 230000003115 biocidal effect Effects 0.000 claims abstract description 37
- 230000007923 virulence factor Effects 0.000 claims abstract description 23
- 239000000304 virulence factor Substances 0.000 claims abstract description 23
- 150000002500 ions Chemical class 0.000 claims description 100
- 238000004458 analytical method Methods 0.000 claims description 65
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims description 37
- 238000001819 mass spectrum Methods 0.000 claims description 32
- 230000000813 microbial effect Effects 0.000 claims description 30
- 238000013375 chromatographic separation Methods 0.000 claims description 27
- 239000000284 extract Substances 0.000 claims description 26
- 238000004587 chromatography analysis Methods 0.000 claims description 25
- 239000002243 precursor Substances 0.000 claims description 22
- 239000002904 solvent Substances 0.000 claims description 21
- 239000012530 fluid Substances 0.000 claims description 19
- 230000008569 process Effects 0.000 claims description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 18
- 238000000132 electrospray ionisation Methods 0.000 claims description 18
- 238000000926 separation method Methods 0.000 claims description 14
- 239000002594 sorbent Substances 0.000 claims description 14
- 238000013467 fragmentation Methods 0.000 claims description 13
- 238000006062 fragmentation reaction Methods 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 230000036961 partial effect Effects 0.000 claims description 12
- 241000894007 species Species 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 238000001360 collision-induced dissociation Methods 0.000 claims description 10
- 239000000377 silicon dioxide Substances 0.000 claims description 9
- 230000004481 post-translational protein modification Effects 0.000 claims description 8
- 230000001018 virulence Effects 0.000 claims description 8
- 239000002738 chelating agent Substances 0.000 claims description 7
- 238000001802 infusion Methods 0.000 claims description 7
- 238000012545 processing Methods 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 5
- 241000192125 Firmicutes Species 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 230000001413 cellular effect Effects 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- YTAHJIFKAKIKAV-XNMGPUDCSA-N [(1R)-3-morpholin-4-yl-1-phenylpropyl] N-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamate Chemical compound O=C1[C@H](N=C(C2=C(N1)C=CC=C2)C1=CC=CC=C1)NC(O[C@H](CCN1CCOCC1)C1=CC=CC=C1)=O YTAHJIFKAKIKAV-XNMGPUDCSA-N 0.000 claims 1
- 244000005700 microbiome Species 0.000 abstract description 76
- 238000001514 detection method Methods 0.000 abstract description 20
- 238000012512 characterization method Methods 0.000 abstract description 9
- 238000002955 isolation Methods 0.000 abstract description 5
- 238000011156 evaluation Methods 0.000 abstract description 2
- 235000018102 proteins Nutrition 0.000 description 145
- 239000000523 sample Substances 0.000 description 100
- 238000004885 tandem mass spectrometry Methods 0.000 description 54
- 210000004027 cell Anatomy 0.000 description 44
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 36
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 30
- 239000012071 phase Substances 0.000 description 30
- 239000000203 mixture Substances 0.000 description 24
- 239000012634 fragment Substances 0.000 description 23
- 241000588724 Escherichia coli Species 0.000 description 20
- 102000006635 beta-lactamase Human genes 0.000 description 17
- 239000012491 analyte Substances 0.000 description 16
- 238000013459 approach Methods 0.000 description 16
- 238000003556 assay Methods 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 15
- 108090000204 Dipeptidase 1 Proteins 0.000 description 15
- 235000019253 formic acid Nutrition 0.000 description 15
- 239000002245 particle Substances 0.000 description 14
- 150000001413 amino acids Chemical group 0.000 description 13
- 239000000047 product Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 230000014759 maintenance of location Effects 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 9
- 244000052769 pathogen Species 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 238000000605 extraction Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000004811 liquid chromatography Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000001228 spectrum Methods 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 230000001629 suppression Effects 0.000 description 8
- 230000005526 G1 to G0 transition Effects 0.000 description 7
- 235000001014 amino acid Nutrition 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000003595 spectral effect Effects 0.000 description 6
- 241000222122 Candida albicans Species 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000010494 dissociation reaction Methods 0.000 description 5
- 230000005593 dissociations Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 238000004896 high resolution mass spectrometry Methods 0.000 description 5
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 5
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000006150 trypticase soy agar Substances 0.000 description 5
- 241000204031 Mycoplasma Species 0.000 description 4
- 108010000605 Ribosomal Proteins Proteins 0.000 description 4
- 102000002278 Ribosomal Proteins Human genes 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 238000001211 electron capture detection Methods 0.000 description 4
- 238000001077 electron transfer detection Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 230000007717 exclusion Effects 0.000 description 4
- 238000004401 flow injection analysis Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000005040 ion trap Methods 0.000 description 4
- 239000003607 modifier Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 238000002553 single reaction monitoring Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000191070 Escherichia coli ATCC 8739 Species 0.000 description 3
- 241000191948 Kocuria rosea Species 0.000 description 3
- 241000187480 Mycobacterium smegmatis Species 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 241000191973 Staphylococcus xylosus Species 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000003466 anti-cipated effect Effects 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000011208 chromatographic data Methods 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 238000011033 desalting Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000012160 loading buffer Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000002552 multiple reaction monitoring Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000011877 solvent mixture Substances 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 108020004256 Beta-lactamase Proteins 0.000 description 2
- 241000194030 Enterococcus gallinarum Species 0.000 description 2
- 238000004252 FT/ICR mass spectrometry Methods 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 241000607768 Shigella Species 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000000065 atmospheric pressure chemical ionisation Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000000451 chemical ionisation Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 2
- 238000002546 full scan Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000002013 hydrophilic interaction chromatography Methods 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 238000001869 matrix assisted laser desorption--ionisation mass spectrum Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- UWYHMGVUTGAWSP-JKIFEVAISA-N oxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 UWYHMGVUTGAWSP-JKIFEVAISA-N 0.000 description 2
- 229960001019 oxacillin Drugs 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 238000012805 post-processing Methods 0.000 description 2
- 230000027756 respiratory electron transport chain Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000002098 selective ion monitoring Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 238000001323 two-dimensional chromatography Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 108050003931 30S ribosomal proteins Proteins 0.000 description 1
- 101710135889 50S ribosomal protein L17 Proteins 0.000 description 1
- 101710135913 50S ribosomal protein L27 Proteins 0.000 description 1
- 102100023777 60S ribosomal protein L31 Human genes 0.000 description 1
- 241000588626 Acinetobacter baumannii Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- KAKUMUHCVOXVMV-UHFFFAOYSA-N CC(CC1C)C11C(C)CCC1 Chemical compound CC(CC1C)C11C(C)CCC1 KAKUMUHCVOXVMV-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 108010054814 DNA Gyrase Proteins 0.000 description 1
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 1
- 101710096438 DNA-binding protein Proteins 0.000 description 1
- 101710116895 DNA-binding protein H-NS Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 101001113903 Grapevine leafroll-associated virus 3 (isolate United States/NY1) Protein P4 Proteins 0.000 description 1
- 108010015268 Integration Host Factors Proteins 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 108090000988 Lysostaphin Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 101710120263 Nucleoid-associated protein YbaB Proteins 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000017033 Porins Human genes 0.000 description 1
- 108010013381 Porins Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010076504 Protein Sorting Signals Chemical group 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical group [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 108090000180 Ribosomal protein L31 Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 101710131156 Uncharacterized protein YehE Proteins 0.000 description 1
- 101710100170 Unknown protein Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003095 anti-phagocytic effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000009112 empiric therapy Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 238000010265 fast atom bombardment Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229960004198 guanidine Drugs 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000010813 internal standard method Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000000752 ionisation method Methods 0.000 description 1
- 238000000050 ionisation spectroscopy Methods 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 238000012923 label-free technique Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 238000001254 matrix assisted laser desorption--ionisation time-of-flight mass spectrum Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000001466 metabolic labeling Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000013365 molecular weight analysis method Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 238000002663 nebulization Methods 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- QVGXLLKOCUKJST-IGMARMGPSA-N oxygen-16 atom Chemical group [16O] QVGXLLKOCUKJST-IGMARMGPSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 238000000734 protein sequencing Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 102000028701 rRNA binding proteins Human genes 0.000 description 1
- 108091009356 rRNA binding proteins Proteins 0.000 description 1
- 238000012950 reanalysis Methods 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 238000001195 ultra high performance liquid chromatography Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/0027—Methods for using particle spectrometers
- H01J49/0031—Step by step routines describing the use of the apparatus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
- G01N33/6851—Methods of protein analysis involving laser desorption ionisation mass spectrometry
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/0027—Methods for using particle spectrometers
- H01J49/0036—Step by step routines describing the handling of the data generated during a measurement
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/02—Details
- H01J49/10—Ion sources; Ion guns
- H01J49/16—Ion sources; Ion guns using surface ionisation, e.g. field-, thermionic- or photo-emission
- H01J49/165—Electrospray ionisation
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13722228.7A EP2845011B1 (en) | 2012-05-01 | 2013-05-01 | Apparatus and methods for microbiological analysis |
AU2013256355A AU2013256355B2 (en) | 2012-05-01 | 2013-05-01 | Apparatus and methods for microbiological analysis |
BR112014027450A BR112014027450A2 (en) | 2012-05-01 | 2013-05-01 | apparatus and methods of microbiological analysis |
CN201380035676.8A CN104797939B (en) | 2012-05-01 | 2013-05-01 | The apparatus and method of microbiological analysis |
JP2015510437A JP6430369B2 (en) | 2012-05-01 | 2013-05-01 | Apparatus and method for microbiological analysis |
IN9493DEN2014 IN2014DN09493A (en) | 2012-05-01 | 2013-05-01 | |
EP17197814.1A EP3290925B1 (en) | 2012-05-01 | 2013-05-01 | Apparatus and methods for microbiological analysis |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261687785P | 2012-05-01 | 2012-05-01 | |
US61/687,785 | 2012-05-01 | ||
US13/874,213 US9074236B2 (en) | 2012-05-01 | 2013-04-30 | Apparatus and methods for microbial identification by mass spectrometry |
US13/874,213 | 2013-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013166169A1 true WO2013166169A1 (en) | 2013-11-07 |
Family
ID=48428681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2013/039094 WO2013166169A1 (en) | 2012-05-01 | 2013-05-01 | Apparatus and methods for microbiological analysis |
Country Status (8)
Country | Link |
---|---|
US (3) | US9074236B2 (en) |
EP (2) | EP2845011B1 (en) |
JP (2) | JP6430369B2 (en) |
CN (2) | CN104797939B (en) |
AU (1) | AU2013256355B2 (en) |
BR (1) | BR112014027450A2 (en) |
IN (1) | IN2014DN09493A (en) |
WO (1) | WO2013166169A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104797939A (en) * | 2012-05-01 | 2015-07-22 | 奥克索伊德有限公司 | Apparatus and methods for microbiological analysis |
WO2016011355A1 (en) | 2014-07-18 | 2016-01-21 | Thermo Finnigan Llc | Methods for mass spectrometry of mixtures of proteins of polypeptides using proton transfer reaction |
WO2016145331A1 (en) * | 2015-03-12 | 2016-09-15 | Thermo Finnigan Llc | Methods for data-dependent mass spectrometry of mixed biomolecular analytes |
EP3193174A1 (en) | 2016-01-14 | 2017-07-19 | Thermo Finnigan LLC | Methods for top-down multiplexed mass spectral analysis of mixtures of proteins or polypeptides |
EP3193352A1 (en) | 2016-01-14 | 2017-07-19 | Thermo Finnigan LLC | Methods for mass spectrometric based characterization of biological molecules |
CN108761084A (en) * | 2018-05-23 | 2018-11-06 | 同济大学 | A kind of complete N- glycoprotein primary structure comprehensive identification method |
CN111524549A (en) * | 2020-03-31 | 2020-08-11 | 中国科学院计算技术研究所 | Integral protein identification method based on ion index |
US11137406B2 (en) | 2016-03-31 | 2021-10-05 | Shimadzu Corporation | Method for discriminating microorganism |
US11442064B2 (en) | 2016-08-25 | 2022-09-13 | Thermo Fisher Scientific Oy | Mass spectrometric methods and kits to identify a microorganism |
US11898192B2 (en) * | 2014-08-14 | 2024-02-13 | bioMérieux | Method for quantifying at least one microorganism group via mass spectrometry |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2686336T3 (en) | 2011-04-21 | 2018-10-17 | Biomerieux, Inc | Method of detecting at least one mechanism of resistance to carbapenems by mass spectrometry |
EP3043175A4 (en) * | 2013-09-04 | 2016-08-31 | Shimadzu Corp | Data-processing apparatus for chromatography mass spectrometry |
JP6238069B2 (en) * | 2014-03-20 | 2017-11-29 | 株式会社島津製作所 | Microbial identification method |
EP3256847A4 (en) * | 2015-02-11 | 2018-10-10 | DH Technologies Development Pte. Ltd. | Rapid detection of microbial resistance to lactam antibiotics by lc-ms/ms |
CN106404474B (en) * | 2015-12-25 | 2018-03-06 | 首都医科大学附属北京同仁医院 | Filamentous fungi Mass Spectrometric Identification protein extracting process |
WO2017127733A1 (en) | 2016-01-20 | 2017-07-27 | Thermo Finnigan Llc | Rapid mass spectrometry methods for antimicrobial susceptibility testing using top-down mass spectrometry |
EP3438655B1 (en) * | 2016-03-31 | 2021-02-17 | Shimadzu Corporation | Microorganism identification method |
US9960027B2 (en) | 2016-05-25 | 2018-05-01 | Thermo Finnigan Llc | Analyzing a complex sample by MS/MS using isotopically-labeled standards |
CN109964300B (en) | 2016-10-07 | 2022-07-15 | 萨莫芬尼根有限责任公司 | System and method for real-time isotope identification |
US10539569B2 (en) * | 2017-01-19 | 2020-01-21 | Asta Corporation | Apparatus and method for processing data of time-of-flight mass spectrometry |
KR102124688B1 (en) * | 2017-01-19 | 2020-06-18 | 주식회사 아스타 | Apparatus and method for processing data of time-of-flight mass spectrometry |
US11092597B2 (en) | 2017-02-28 | 2021-08-17 | Waters Technoligies Corporation | Devices and methods for analyzing intact proteins, antibodies, antibody subunits, and antibody drug conjugates |
SG11202000968TA (en) * | 2017-08-07 | 2020-02-27 | Agency Science Tech & Res | Rapid analysis and identification of lipids from liquid chromatography-mass spectrometry (lc-ms) data |
US20190062809A1 (en) * | 2017-08-24 | 2019-02-28 | Clinical Micro Sensors, Inc. (dba GenMark Diagnostics, Inc.) | Electrochemical detection of bacterial and/or fungal infections |
JP7105049B2 (en) * | 2017-10-02 | 2022-07-22 | 日本電子株式会社 | Mass spectrometry data processing device and mass spectrometry data processing method |
KR20190054921A (en) * | 2017-11-14 | 2019-05-22 | 주식회사 노스퀘스트 | Mass spectrometric diagnosis apparatus and method for antimicrobial resistant bacteria inducing antibiotic modification |
CN112368561A (en) * | 2018-05-25 | 2021-02-12 | 克维拉公司 | Methods and compositions for selective lysis of blood cells and isolation of microbial cells |
DE102018114028A1 (en) * | 2018-06-12 | 2019-12-12 | Bundesrepublik Deutschland (Robert Koch-Institut) | Sample preparation for proteomic examinations |
US20220178941A1 (en) * | 2019-04-03 | 2022-06-09 | Shimadzu Corporation | Analysis method, microorganism identification method, and testing method |
US11879897B2 (en) * | 2019-05-30 | 2024-01-23 | Thermo Finnigan Llc | Operating a mass spectrometer utilizing mass spectral database search |
FR3103197A1 (en) * | 2019-11-15 | 2021-05-21 | bioMérieux | DETERMINATION BY MASS SPECTROMETRY OF THE SENSITIVITY OR RESISTANCE OF BACTERIA TO AN ANTIBIOTIC |
FR3106414B1 (en) * | 2020-01-17 | 2021-12-24 | Centre Nat Rech Scient | Method for identifying and characterizing a microbial population by mass spectrometry |
RU2739758C1 (en) * | 2020-03-05 | 2020-12-28 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) | Method for identifying candida spp_ and other yeast-like fungi from positive blood culture by matrix laser desorption ionization time-of-flight mass spectrometry (maldi-tof ms) in patients with blood flow infection |
JP2023521156A (en) | 2020-04-06 | 2023-05-23 | ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | Proadrenomedullin for Prognosing Disease Progression in Severe Acute Respiratory Syndrome (SARS) |
EP4133281A1 (en) | 2020-04-09 | 2023-02-15 | B.R.A.H.M.S GmbH | Biomarkers for the diagnosis of respiratory tract infections |
WO2021263123A1 (en) * | 2020-06-26 | 2021-12-30 | Thermo Fisher Scientific Oy | Rapid mass spectrometric methods for identifying microbes and antibiotic resistance proteins |
WO2022074454A1 (en) | 2020-10-06 | 2022-04-14 | Thermo Fisher Scientific Oy | Systems and methods for rapid microbial identification |
US11721538B2 (en) * | 2020-11-17 | 2023-08-08 | Thermo Finnigan Llc | Feeding real time search results of chimeric MS2 spectra into the dynamic exclusion list |
CN114200044A (en) * | 2021-12-01 | 2022-03-18 | 中国林业科学研究院林业研究所 | Identification method of gallnut tannin component based on UHPLC-ESI-QTOF-MS/MS |
WO2023110832A1 (en) | 2021-12-13 | 2023-06-22 | UNIVERSITé LAVAL | Biomarkers for the prediction of preterm birth |
CN115902065A (en) * | 2022-12-07 | 2023-04-04 | 中国检验检疫科学研究院 | Method for detecting non-volatile derivative generated by triglyceride in vegetable oil |
CN117491536B (en) * | 2023-12-29 | 2024-03-12 | 中国林业科学研究院林产化学工业研究所 | Method for identifying microbial toxic substances in pulping wastewater of PRC-APMP (PRC-APMP) process |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009065580A1 (en) * | 2007-11-23 | 2009-05-28 | Bruker Daltonik Gmbh | Identification of pathogens in body fluids |
WO2009134120A1 (en) * | 2008-04-29 | 2009-11-05 | Erasmus University Medical Center Rotterdam | Mass spectrometric analysis of small molecule analytes |
WO2011006911A2 (en) * | 2009-07-16 | 2011-01-20 | Bruker Daltonik Gmbh | Mass spectrometric diagnosis of septicemia |
WO2012058632A1 (en) | 2010-10-29 | 2012-05-03 | Thermo Fisher Scientific Oy | Automated system for sample preparation and analysis |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9617852D0 (en) * | 1996-08-27 | 1996-10-09 | Univ Manchester Metropolitan | Micro-organism identification |
US6296771B1 (en) | 1999-04-02 | 2001-10-02 | Symyx Technologies, Inc. | Parallel high-performance liquid chromatography with serial injection |
US20020155587A1 (en) | 2001-04-20 | 2002-10-24 | Sequenom, Inc. | System and method for testing a biological sample |
EP1428019A4 (en) | 2001-07-13 | 2006-04-26 | Syngenta Participations Ag | System and method of determining proteomic differences |
US20030141253A1 (en) | 2001-12-07 | 2003-07-31 | Bihan Thierry Le | Apparatus for efficient liquid chromatography/mass spectrometry processing |
US20030124539A1 (en) | 2001-12-21 | 2003-07-03 | Affymetrix, Inc. A Corporation Organized Under The Laws Of The State Of Delaware | High throughput resequencing and variation detection using high density microarrays |
US20050221500A1 (en) * | 2002-05-20 | 2005-10-06 | Purdue Research Foundation | Protein identification from protein product ion spectra |
WO2006089103A1 (en) | 2005-02-18 | 2006-08-24 | Kalypsys, Inc. | Automated evaluation of target samples in a high performance analysis system |
CN101034087B (en) * | 2006-03-10 | 2011-08-31 | 中国科学院沈阳应用生态研究所 | In-situ degrading bacteria in polycyclic aromatic hydrocarbons polluting soil and identification method of bioremediation capability |
US8160819B2 (en) | 2008-08-22 | 2012-04-17 | The United States Of America, As Represented By The Secretary Of Agriculture | Rapid identification of proteins and their corresponding source organisms by gas phase fragmentation and identification of protein biomarkers |
CN101363056A (en) * | 2008-09-11 | 2009-02-11 | 浙江大学 | High-flux microorganism identification method |
US8224581B1 (en) * | 2009-06-18 | 2012-07-17 | The United States Of America As Represented By The Secretary Of The Army | Methods for detection and identification of cell type |
FR2951548B1 (en) * | 2009-10-15 | 2011-11-11 | Biomerieux Sa | METHOD FOR CHARACTERIZING AT LEAST ONE MICROORGANISM BY MASS SPECTROMETRY |
US9074236B2 (en) | 2012-05-01 | 2015-07-07 | Oxoid Limited | Apparatus and methods for microbial identification by mass spectrometry |
-
2013
- 2013-04-30 US US13/874,213 patent/US9074236B2/en active Active
- 2013-05-01 CN CN201380035676.8A patent/CN104797939B/en active Active
- 2013-05-01 EP EP13722228.7A patent/EP2845011B1/en active Active
- 2013-05-01 IN IN9493DEN2014 patent/IN2014DN09493A/en unknown
- 2013-05-01 JP JP2015510437A patent/JP6430369B2/en active Active
- 2013-05-01 AU AU2013256355A patent/AU2013256355B2/en active Active
- 2013-05-01 CN CN201710950149.XA patent/CN107677836A/en active Pending
- 2013-05-01 WO PCT/US2013/039094 patent/WO2013166169A1/en active Application Filing
- 2013-05-01 BR BR112014027450A patent/BR112014027450A2/en active Search and Examination
- 2013-05-01 EP EP17197814.1A patent/EP3290925B1/en active Active
-
2015
- 2015-05-22 US US14/720,360 patent/US10157734B2/en active Active
-
2018
- 2018-04-05 US US15/945,997 patent/US20180233340A1/en active Pending
- 2018-06-04 JP JP2018106663A patent/JP6668415B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009065580A1 (en) * | 2007-11-23 | 2009-05-28 | Bruker Daltonik Gmbh | Identification of pathogens in body fluids |
WO2009134120A1 (en) * | 2008-04-29 | 2009-11-05 | Erasmus University Medical Center Rotterdam | Mass spectrometric analysis of small molecule analytes |
WO2011006911A2 (en) * | 2009-07-16 | 2011-01-20 | Bruker Daltonik Gmbh | Mass spectrometric diagnosis of septicemia |
WO2012058632A1 (en) | 2010-10-29 | 2012-05-03 | Thermo Fisher Scientific Oy | Automated system for sample preparation and analysis |
WO2012058559A2 (en) | 2010-10-29 | 2012-05-03 | Thermo Fisher Scientific Oy | System layout for an automated system for sample preparation and analysis |
Non-Patent Citations (1)
Title |
---|
FROHM M ET AL: "BIOCHEMICAL AND ANTIBACTERIAL ANALYSIS OF HUMAN WOUND AND BLISTER FLUID", EUROPEAN JOURNAL OF BIOCHEMISTRY, PUBLISHED BY SPRINGER-VERLAG ON BEHALF OF THE FEDERATION OF EUROPEAN BIOCHEMICAL SOCIETIES, vol. 237, no. 1, 1 April 1996 (1996-04-01), pages 86 - 92, XP000863693, ISSN: 0014-2956, DOI: 10.1111/J.1432-1033.1996.0086N.X * |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10157734B2 (en) | 2012-05-01 | 2018-12-18 | Oxiod Limited | Methods for microbial identification by mass spectrometry |
CN104797939A (en) * | 2012-05-01 | 2015-07-22 | 奥克索伊德有限公司 | Apparatus and methods for microbiological analysis |
EP3779454A1 (en) | 2014-07-18 | 2021-02-17 | Thermo Finnigan LLC | Methods for mass spectrometry of mixtures of proteins or polypeptides using proton transfer reaction |
US9837255B2 (en) | 2014-07-18 | 2017-12-05 | Thermo Finnigan Llc | Methods for mass spectrometry of mixtures of protein or polypeptides using proton transfer reaction |
WO2016011355A1 (en) | 2014-07-18 | 2016-01-21 | Thermo Finnigan Llc | Methods for mass spectrometry of mixtures of proteins of polypeptides using proton transfer reaction |
US10497549B2 (en) | 2014-07-18 | 2019-12-03 | Thermo Finnigan Llc | Methods for mass spectrometry of mixtures of proteins or polypeptides using proton transfer reaction |
US11898192B2 (en) * | 2014-08-14 | 2024-02-13 | bioMérieux | Method for quantifying at least one microorganism group via mass spectrometry |
WO2016145331A1 (en) * | 2015-03-12 | 2016-09-15 | Thermo Finnigan Llc | Methods for data-dependent mass spectrometry of mixed biomolecular analytes |
US10217619B2 (en) | 2015-03-12 | 2019-02-26 | Thermo Finnigan Llc | Methods for data-dependent mass spectrometry of mixed intact protein analytes |
EP3460481A1 (en) | 2016-01-14 | 2019-03-27 | Thermo Finnigan LLC | Methods for top-down multiplexed mass spectral analysis of mixtures of proteins or polypeptides |
US10151758B2 (en) | 2016-01-14 | 2018-12-11 | Thermo Finnigan Llc | Methods for top-down multiplexed mass spectral analysis of mixtures of proteins or polypeptides |
EP3193174A1 (en) | 2016-01-14 | 2017-07-19 | Thermo Finnigan LLC | Methods for top-down multiplexed mass spectral analysis of mixtures of proteins or polypeptides |
US10458994B2 (en) | 2016-01-14 | 2019-10-29 | Thermo Finnigan Llc | Methods for mass spectrometric based characterization of biological molecules |
US10101335B2 (en) | 2016-01-14 | 2018-10-16 | Thermo Finnigan Llc | Methods for mass spectrometric based characterization of biological molecules |
EP3193352A1 (en) | 2016-01-14 | 2017-07-19 | Thermo Finnigan LLC | Methods for mass spectrometric based characterization of biological molecules |
US11137406B2 (en) | 2016-03-31 | 2021-10-05 | Shimadzu Corporation | Method for discriminating microorganism |
US11442064B2 (en) | 2016-08-25 | 2022-09-13 | Thermo Fisher Scientific Oy | Mass spectrometric methods and kits to identify a microorganism |
CN108761084A (en) * | 2018-05-23 | 2018-11-06 | 同济大学 | A kind of complete N- glycoprotein primary structure comprehensive identification method |
CN111524549A (en) * | 2020-03-31 | 2020-08-11 | 中国科学院计算技术研究所 | Integral protein identification method based on ion index |
CN111524549B (en) * | 2020-03-31 | 2023-04-25 | 中国科学院计算技术研究所 | Integral protein identification method based on ion index |
Also Published As
Publication number | Publication date |
---|---|
JP2018183140A (en) | 2018-11-22 |
EP3290925A1 (en) | 2018-03-07 |
JP6430369B2 (en) | 2018-11-28 |
AU2013256355A1 (en) | 2014-11-27 |
CN104797939B (en) | 2017-11-21 |
BR112014027450A2 (en) | 2017-06-27 |
US20150255261A1 (en) | 2015-09-10 |
CN107677836A (en) | 2018-02-09 |
US20180233340A1 (en) | 2018-08-16 |
US20140051113A1 (en) | 2014-02-20 |
US20190006161A9 (en) | 2019-01-03 |
AU2013256355B2 (en) | 2018-11-29 |
EP2845011A1 (en) | 2015-03-11 |
US9074236B2 (en) | 2015-07-07 |
JP6668415B2 (en) | 2020-03-18 |
IN2014DN09493A (en) | 2015-07-17 |
JP2015521035A (en) | 2015-07-27 |
CN104797939A (en) | 2015-07-22 |
EP2845011B1 (en) | 2017-12-27 |
EP3290925B1 (en) | 2023-04-12 |
US10157734B2 (en) | 2018-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10157734B2 (en) | Methods for microbial identification by mass spectrometry | |
US10497549B2 (en) | Methods for mass spectrometry of mixtures of proteins or polypeptides using proton transfer reaction | |
CA2495378C (en) | Method for characterizing biomolecules utilizing a result driven strategy | |
US10151758B2 (en) | Methods for top-down multiplexed mass spectral analysis of mixtures of proteins or polypeptides | |
US20220050090A1 (en) | Mass spectrometry assay method for detection and quantitation of microbiota related metabolites | |
US11199547B2 (en) | Methods and systems for LC-MS/MS proteomic genotyping | |
US10101335B2 (en) | Methods for mass spectrometric based characterization of biological molecules | |
US20110224104A1 (en) | Method and system for indentification of microorganisms | |
Gant et al. | Present and Future Perspectives on Mass Spectrometry for Clinical Microbiology |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13722228 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013722228 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2015510437 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2013256355 Country of ref document: AU Date of ref document: 20130501 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112014027450 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112014027450 Country of ref document: BR Kind code of ref document: A2 Effective date: 20141103 |